Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,742 across all filing types
Latest filing 2025-02-21 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
上市公司独立董事候选人声明与承诺(王双)
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement by an independent director candidate for a listed company. It includes statements about qualifications, compliance with laws and regulations, and commitments to fulfill duties independently. There is no financial data, no report of financial results, no voting results, no management changes, no legal proceedings, or other typical report content. It is a regulatory compliance document related to board/management information, specifically about the nomination and qualifications of an independent director candidate. Therefore, it fits best under Board/Management Information (MANG). The document length is under 5,000 characters, but it is not an announcement of a report publication or a certification letter; it is a formal declaration related to board management.
2025-02-21 Chinese
上市公司独立董事提名人声明与承诺(王双)
Board/Management Information Classification · 100% confidence The document is a detailed nomination statement and commitment declaration for an independent director candidate for the company's board. It includes compliance with various laws, regulations, and qualifications for the independent director role. There is no financial data, no report of financial results, no voting results, no meeting materials, and no announcement of a report publication. The content is focused on board/management information, specifically the nomination and qualifications of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is sufficient and contains substantive content related to board nomination, not a mere announcement or certification.
2025-02-21 Chinese
简式权益变动报告书(董海)
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of an individual named 董海 in the company 绿康生化股份有限公司, including the nature of the shareholding change, the number of shares before and after, and the legal and regulatory basis for the disclosure. The document references relevant Chinese securities laws and regulations, and it includes detailed information about the shareholding change, the purpose, and the procedures involved. This type of document is a notification of a major shareholding change, specifically when a shareholder crosses the 5% ownership threshold. It is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes. Therefore, the correct classification is Major Shareholding Notification (MRQ). The document length (6326 characters) and content confirm it is a full report of the shareholding change, not just an announcement or a certification, so it is not RNS or RPA.
2025-02-18 Chinese
关于持股5%以上股东解散清算的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a detailed announcement regarding the dissolution and liquidation of a shareholder holding more than 5% of the company's shares, and the subsequent non-trade transfer of shares to other parties. It includes information about shareholder identities, shareholding proportions, and commitments related to shareholding and reduction plans. The document does not contain financial statements or performance data, nor is it a report or presentation. It is a regulatory announcement about changes in major shareholding and related compliance matters. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is 3312 characters, which is consistent with a detailed announcement rather than a brief notice or a full report.
2025-02-18 Chinese
简式权益变动报告书(厦门国际信托)
Major Shareholding Notification Classification · 95% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report" or "Equity Change Report". It details the change in shareholding of the information disclosure obligor (厦门国际信托有限公司) in the listed company 绿康生化股份有限公司. The document includes sections on the purpose of the equity change, the method of change, shareholding percentages before and after the change, and legal compliance statements. It references relevant Chinese securities laws and regulations governing equity changes and disclosures. There is no indication that this is an annual report, earnings release, or any other financial report. Instead, it is a formal disclosure of a change in major shareholding, specifically crossing the 5% ownership threshold. This fits the definition of "Major Shareholding Notification (Code: MRQ)". The document length (7328 characters) and detailed content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2025-02-18 Chinese
简式权益变动报告书(慈荫投资)
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of the information disclosure obligor (杭州慈荫投资合伙企业) in the listed company 绿康生化股份有限公司. The document includes detailed information about the shareholding changes, the purpose of the change, the method of change (non-trading transfer due to dissolution of the investment partnership), and the impact on shareholding percentages. It also references relevant Chinese securities laws and regulations governing equity changes and disclosures. The document is not an annual or quarterly financial report, nor is it an earnings release, audit report, or management report. It is a formal disclosure of a change in major shareholding, specifically a reduction in shares held by a significant shareholder. Therefore, the document fits the category of Major Shareholding Notification (MRQ). The document length (7042 characters) and detailed content confirm it is the report itself, not just an announcement of a report publication or a certification letter.
2025-02-18 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.